Sort
10,766 grants matching “checkpoint inhibitor”
GEN - Project
$27,843P. Todd Stukenberg · University Of Virginia · P30 · FY2023 · CA
Elucidating the Mechanism of CDK4/6 Inhibitor-Mediated Radiosensitization of ER+ Breast Cancers
$27,075Andrea Michelle Pesch · University Of Michigan At Ann Arbor · F31 · FY2021 · CA
Experimental Therapeutics
$26,996Vern L. Schramm · Albert Einstein College Of Medicine · P30 · FY2019 · CA
Experimental Therapeutics
$26,996Vern L. Schramm · Albert Einstein College Of Medicine · P30 · FY2020 · CA
Checkpoint Regulation of Stalled and Collapsed Replication Forks
$26,878Frank Benjamin Couch · Vanderbilt University · F31 · FY2012 · CA
Project 1: Developing Immune Checkpoint Controlled Release Biomaterials for Caner Immunotherapy
$26,435Richard Mu · Tennessee State University · U54 · FY2023 · CA
Metabolic Contributions of Individual Cellular Compartments to the Diversity of the Tumor Microenvironment in Renal Cell Carcinoma
$26,412Bradley Reinfeld · Vanderbilt University · F30 · FY2023 · CA
Cancer Immunology
$26,344Nina Bhardwaj · Icahn School Of Medicine At Mount Sinai · P30 · FY2022 · CA
Cancer Immunology
$26,344Nina Bhardwaj · Icahn School Of Medicine At Mount Sinai · P30 · FY2021 · CA
Cancer Immunology
$26,344Nina Bhardwaj · Icahn School Of Medicine At Mount Sinai · P30 · FY2024 · CA
Cancer Immunology
$26,344Nina Bhardwaj · Icahn School Of Medicine At Mount Sinai · P30 · FY2020 · CA
Cancer Immunology
$26,344Nina Bhardwaj · Icahn School Of Medicine At Mount Sinai · P30 · FY2023 · CA
Biochemical Studies of Human DNA Polymerase Delta
$26,320New York Medical College · R01 · FY2005 · GM
Targeting Ribosomal Biogenesis in Prostate Cancer
$26,010Everardo Macias · Cedars-Sinai Medical Center · K22 · FY2017 · CA
Characterizing mechanisms and consequences of intergenic transcription in human cancers
$25,943Vinayak Venkatasesha Viswanadham · Harvard Medical School · F31 · FY2022 · CA
HTS to Identify Small Molecule Inhibitors of Phospho-Specific Protein-Protein Int
$25,000Amarnath Natarajan · University Of Texas Med Br Galveston · R03 · FY2007 · MH
Layer-by-Layer Nanoparticles for Combination Cytokine Immunotherapy of Ovarian Cancer
$24,894Sean Gregory Smith · Massachusetts Institute Of Technology · F32 · FY2020 · CA
Identifying the role of Ntrk1 in immunosuppression in Kras/p53 mutant lung cancer
$24,777Jessica Konen · University Of Tx Md Anderson Can Ctr · F32 · FY2022 · CA
Development of a tumor-activated IL12 prodrug to treat solid tumors
$24,724Benjamin Moon · Ut Southwestern Medical Center · F30 · FY2024 · CA
25 Cancer Genetics and Epigenetics
$24,692Richard D Wood · University Of Tx Md Anderson Can Ctr · P30 · FY2025 · CA
07 Gastrointestinal Cancers
$24,691Scott Kopetz · University Of Tx Md Anderson Can Ctr · P30 · FY2025 · CA
11 Prostate Cancer
$24,690Christopher J. Logothetis · University Of Tx Md Anderson Can Ctr · P30 · FY2025 · CA
Role of cell-intrinsic effects of PD-L1 in carcinogenesis
$24,560Anand Kornepati · University Of Texas Hlth Science Center · F30 · FY2023 · CA
PROTEOLYSIS AND MAMMALIAN GL/S CELL CYCLE TRANSITION
$24,525Yale University · R01 · FY2003 · CA
Mechanisms of Immune Dysfunction and Morbid Outcome in Response to Shock/Sepsis
$24,324Alfred Ayala · Rhode Island Hospital · R35 · FY2019 · GM